BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer

Concurrent/adjuvant cisplatin-based chemoradiotherapy is regarded as the standard of treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). However, patients who do not respond to cisplatin suffer, rather than benefit, from chemotherapy treatment. The goal of this study was to identif...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell Death Dis
Hlavní autoři: Kuang, Chun-mei, Fu, Xiang, Hua, Yi-jun, Shuai, Wen-di, Ye, Zhi-hua, Li, Yingchang, Peng, Qi-hua, Li, Yi-zhuo, Chen, Shuai, Qian, Chao-nan, Huang, Wenlin, Liu, Ran-yi
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520926/
https://ncbi.nlm.nih.gov/pubmed/28617432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.271
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky